When your biological age is older than your chronological age, the risk of getting and dying of cancer rises
Marla Paul, Northwestern University, February 17, 2016
Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.
Corre R, Greillier L, Le Caër H, Audigier-Valette C, Baize N, Bérard H, Falchero L, Monnet I, Dansin E, Vergnenègre A, Marcq M, Decroisette C, [...]
Treating recurrent postmenopausal vasomotor symptoms in a patient with a positive family history for breast cancer.
Leong C, Lake J. Consult Pharm. 2015 Jan;30(1):38-44. doi: 10.4140/TCP.n.2015.38.
Why the oncologist should consider the nutritional status of the elderly cancer patient.
Bozzetti F Nutrition. 2015 Apr;31(4):590-3. doi: 10.1016/j.nut.2014.12.005. Epub 2014 Dec 12.
Treatment of Hodgkin lymphoma in older patients
Radford J. Blood. 2015 Dec 24;126(26):2768-9. doi: 10.1182/blood-2015-10-671388.
Chemoradiation may increase survival for a subset of elderly head and neck cancer patients
Garth Sundem - Colorado Cancer Blog (University of Colorado Cancer Center) Feb. 18, 2016
Elderly risk more complications after major cancer surgery
Lisa Rapaport interviewed several doctors including Dr Siri Rostoft and Dr Kwok-Leung Cheung both SIOG members - Reuters Health
How I treat fragile myeloma patients
Larocca A, Palumbo A. Blood. 2015 Nov 5;126(19):2179-85. doi: 10.1182/blood-2015-05-612960. Epub 2015 Aug 31.
The Prognostic Importance of Frailty in Cancer Survivors
Brown JC, Harhay MO, Harhay MN. J Am Geriatr Soc. 2015 Dec;63(12):2538-2543. doi: 10.1111/jgs.13819. Epub 2015 Nov 14.
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.
Graff JN, Baciarello G, Armstrong AJ, Higano CS, Iversen P, Flaig TW, Forer D, Parli T, Phung D, Tombal B, Beer TM, Sternberg CN. Ann [...]
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907
Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff A, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. J Clin Oncol. [...]
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
Aparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provençal [...]
